During the past decade, Lawson Health Research Institute conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 7 clinical trials were completed, i.e. on average, 18.9% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 5 clinical trials were completed. i.e. 23.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lawson Health Research Institute" #1 sponsor was "Lawson Health Research Institute" with 13 trials, followed by "Evdokia Anagnostou" with 3 trials sponsored, "Actelion" with 2 trials sponsored, "Arrowhead Pharmaceuticals" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 29 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lawson Health Research Institute" #1 collaborator was "Lawson Health Research Institute" with 6 trials as a collaborator, "McMaster University" with 6 trials as a collaborator, "University of Western Ontario, Canada" with 5 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator and "Hamilton Health Sciences Corporation" with 3 trials as a collaborator. Other collaborators include 75 different institutions and companies that were collaborators in the rest 75 trials.

According to Clinical.Site data, the most researched conditions in "Lawson Health Research Institute" are "Idiopathic Pulmonary Fibrosis" (4 trials), "Prostate Cancer" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Autism Spectrum Disorder" (2 trials) and "Autism Spectrum Disorders" (2 trials). Many other conditions were trialed in "Lawson Health Research Institute" in a lesser frequency.

Most popular intervention types in "Lawson Health Research Institute" are "Drug" (25 trials), "Other" (15 trials), "Procedure" (6 trials), "Device" (4 trials) and "Radiation" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Bosentan" (2 trials), "Rosuvastatin" (2 trials), "0SJ-IOMS" (1 trials) and "18F-FCH PET/MRI Scan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lawson Health Research Institute" are 49 trials for "All" genders, 5 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Lawson Health Research Institute". 2 are not yet recruiting, 12 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Lawson Health Research Institute, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Lawson Health Research Institute, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 11 trials that are defined as “Not Applicable".